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aBstraCt
BaCkground: The purpose of this study was to report the outcomes of an extremely rare and misdiagnosed emb-
ryonal neuroepithelial intraocular tumor.
Material and Methods: The medical records of 28 nucleated eyes with unilateral vision loss in childhood and 
young adults were reviewed retrospectively. Demographic information, clinical history, visual acuity, indication for 
surgery, and histopathological findings were all noted. Cases of visual loss related to ocular trauma or endophthal-
mitis were not included in this study. B-scan ultrasonography was performed on patients due to media opacity.
results: A total of 7 eyes of 28 patients, age between 1–18 years, who were underwent enucleation surgery for 
intraocular malignancy were included in the study. The mean follow-up period was 29.4 ± 10.2 months (range, 
15–60 months ). The mean age of the patients was 5.85 ± 7.33 years. There were four females and three males with 
equal eye distribution. The patients had no light perception. Five of 7 patients were operated on for retinoblastoma 
in the early period of life with easily recognized clinical signs. The other two patients wanted surgery just because 
they were uncomfortable with the appearance of their eyes. One of them was a 15-year-old girl with a history of 
blind eye and glaucoma. She had been treated for congenital glaucoma since the age of 5. At the time of the research 
she was complaining about the painful, blind eye as an aesthetic defect. Histopathological diagnosis was reported 
as medulloepithelioma. As a long-term complication, submandibular lymph node metastasis was detected during 
the follow-up period. Otolaryngologists performed the radical neck dissection. The patient received radiotherapy 
and chemotherapy. She is now in her 30s. No other complication was observed during the follow-up period. The 
other patient was an 18-years-old boy, who had lost his vision for an unknown cause in childhood, and wanted to 
have surgery for aesthetic purposes due to opaque cornea. Ultrasonography detected a mass in the ciliary body. The 
enucleation surgery was performed, and histopathological diagnosis was reported as medulloepithelioma. The patient 
received radiotherapy, and no metastasis developed during the follow-up period.
ConClusion: Ophthalmologists need to be more familiar with early diagnoses and screening of the eye, especially 
detecting tumor cases “medulloepithelioma” which is often misdiagnosed and treated as glaucoma.
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introduCtion
Enucleation and evisceration are types of eye re-
moval surgery used as a palliative treatment in cases 
of severe trauma, eye malignancy, endophthalmitis 
unresponsive to medical treatment, painful blind 
eye, absolute glaucoma, and phthisic eyes with se-
vere cosmetic defects [1, 2]. Evisceration surgery is 
usually preferred in extremely severe trauma cases, 
while enucleation is used in advanced cases of in-
traocular malignancy. Both procedures result in an 
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anophthalmic socket [1]. One review study stated 
that trauma accounts for 40.9% of enucleation cas-
es, whereas tumors were 24.2%. In another study, 
endophthalmitis accounted for 45.5% of cases, 
whereas  phthisis bulbi  and trauma together were 
39.5% [2–4]. Malignant intraocular tumors are 
managed by enucleation. This prevents the tumor 
spread into the orbital cavity. Retinoblastoma is one 
of the most common intraocular tumors in the pe-
diatric age group. The other is medulloepithelioma, 
a rare embryonal neuroepithelial tumor arising from 
primitive medulloepithelioma. Medulloepithelioma 
tends to cause secondary glaucoma and often is mis-
diagnosed until adulthood [1, 2, 5–7].
There are some parameters used to distinguish 
these two intraocular tumors. These can be sum-
marized as follows: intraocular cystic changes and 
the location of the more anterior position, such as 
the ciliary body or iris, are more common in me-
dulloepithelioma, whereas retinoblastoma typically 
originates from the retina, and intratumoral calcifi-
cation is a suitable differential parameter since it is 
less observed in medulloepithelioma [8–11].
There is no population-based information on the 
incidence or prevalence of medulloepithelioma. The 
literature consists mostly of single case reports and 
small series [12]. In a study involving 10 patients, 
authors stated that the age of medulloepithelioma 
was between 2 months and 10 years [13].  There 
is also limited information on long-term survival. 
Tumors confined to the globe have an excellent 
prognosis, with a 5-year survival of 90–95% after 
enucleation. Extension of the tumor into the extra-
scleral orbital soft tissues dramatically increases the 
rate of metastatic disease and recurrence, resulting 
in a poor overall prognosis.[14]
In our study, we wanted to emphasize the im-
portance of the early diagnosis and treatment of 
medulloepithelioma, a rare childhood intraocu-
lar tumor.
Material and Methods
The medical records of 7 eyes of 28 patients 
under 20 years of age were reviewed retrospectively. 
The study protocol adhered to the tenets of the 
Declaration of Helsinki and was approved by the 
ethics committee. Fully informed, written consent 
forms from patients were obtained. The patients’ 
demographic information, clinical history, visual 
acuity, indication for surgery, duration of follow-up, 
complications encountered during the follow-up 
period, and histopathological findings were all 
noted. B-scan ultrasonography was performed on 
patients due to media opacity. Inclusion criteria for 
enucleations were: eye malignancy unresponsive to 
medical therapies or eye malignancy when medical 
treatments were impossible at the advanced stages 
during the diagnosis. Exclusion criteria were visual 
loss related to ocular trauma or endophthalmitis.
results
Seven eyes of 28 patients (aged between 1 and 
18 years) underwent evisceration or enucleation 
surgery between 2000 and 2018. The mean fol-
low-up period was 29.4 ± 10.2 months (range 
15–60 months). The average age of all patients was 
5.85 ± 7.33 years. There were four females and three 
males with equal eye distribution. All cases of eye 
removal were uniocular. Related features include 
painful blind eye and glaucoma 14.3% (n = 1), 
retinoblastoma 71.4% (n = 5), and ciliary body 
mass 14.3%(n=1). The patients’ demographics were 
summarized in Table 1.
Of the seven patients who underwent enuclea-
tion, five were operated on for retinoblastoma. One 
patient, who had been treated for congenital glau-
coma for many years and then operated on for 
a painful blind eye, developed cystic dilatation in 
the anophthalmic socket (Fig. 1, 2). 
One patient was operated on for ciliary body 
mass detected on ultrasound. Histopathology of 
two enucleated eyes was reported as medulloepithe-
lioma (Fig. 3); these patients received radiotherapy. 
In one of these two patients, submandibular lymph 
node metastasis extending to the midjuguler region 
was detected as a long term complication during 
the follow-up period.  Radical neck dissection was 
performed by otolaryngologists, and the patient re-
ceived radiotherapy and chemotherapy. The other 
patient received radiotherapy after enucleation sur-
gery. No metastatic finding was observed during the 
follow-up period.
table 1. surgical indications of patients who underwent 
total eye removal 
indication 
number of cases  
n (%)
painful blind eye/absolute glaucoma 1 (14.3%)
Ciliary body mass 1(14.3%)
Malignancy (retinoblastoma) 5 (71.4%)
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disCussion
Enucleation is an accepted modality of treat-
ment for patients with: severely traumatized eyes, 
advanced stages of tumors, and cosmetically un-
acceptable or painful blind eyes [15]. Indications 
of enucleation vary across different centers in the 
world [15]. In a review study, trauma was reported 
as the leading cause of enucleation (40.9% of cases), 
and intraocular tumors were the second leading 
cause (24–28% of cases) [2, 16]. Other conditions 
are glaucoma, and painful blind eye, cosmetically 
unacceptable eye. We performed enucleation sur-
gery in tumors and absolute glaucoma with painful 
eyes. Tumors in our study constituted 25% (n = 7) 
of enucleated eyes.
The most common intraocular tumors of child-
hood are retinoblastoma; 90% of patients are di-
agnosed before reaching the age of five [6, 17, 18]. 
Leukocoria and strabismus are the most common 
first signs of the tumor [6]. Sometimes it can cause 
proptosis [6]. Treatment of retinoblastoma is com-
plex and varied according to its clinical features. If 
left untreated, it will grow and extend beyond the 
eye, invading the regional lymph nodes, bone mar-
row, and the central nervous system [6]. We treated 
five patients diagnosed with retinoblastoma at the 
age of 1- and 2-years-old, performing enucleation 
surgery. We did not encounter any complications 
during follow-up.
Medulloepithelioma is another childhood ocular 
malignancy [17]. It is a rare embryonal neuroepi-
thelial intraocular tumor stemming from primitive 
medullloepithelium, diagnosed in the first decade 
of life [7]. Small medulloepitheliomas of the ciliary 
body go undetected because they are hidden from 
view by the iris. It appears as a gray-white tumor of 
the ciliary body in the early stages. The growth of 
medulloepithelioma is slow, and it is locally invasive. 
Poor vision and pain are the most common present-
ing symptoms. Even after symptoms develop, clinical 
suspicion of a tumor is often overlooked — patients 
are treated for secondary complications of the tumor 
such as cataract or glaucoma before the underlying 
mass is discovered. While it slowly enlarges, the most 
common clinical signs include cyst or mass in the 
iris, anterior chamber, or ciliary body [7, 11, 19]. 
This was clearly seen in our study: one of our pa-
tients suffering from congenital glaucoma underwent 
trabeculotomy procedure. However, absolute glau-
coma of the left eye was noted two years later during 
follow-up. The patient was subsequently operated on 
because of blind painful eye and also unpleasant ap-
pearance. The histopathology was reported as a neu-
Figure 1. preoperative view of the anophtalmic socket 
of the patient with cystic dilatation
Figure 3. a rare embryonal neuroepithelial tumor 
(medulloepithelioma). It composed of poorly differentiated cells 
with hyperchromatic nuclei and high nuclear-to-cytoplasmic 
ratio and pseudostratified epithelium with tubular or trabecular 
arrangements (H & e x 200)
Figure 2. The enucleated orbital content with orbital sphere
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roepithelial tumor (medulloepitelioma). The patient 
was later lost to follow-up. When she came back 
seven months after surgery, she had a small swell-
ing of the right submandibular lymph node. Biopsy 
of the material was reported as medulloepithelioma 
metastasis. The patient was operated on and received 
radiotherapy and chemotherapy.  No recurrence was 
observed during the follow-up period. She is now 
in her 30s, and no other complication was observed 
during the follow-up period. The other patient was 
an 18-years-old boy, who lost his vision for an un-
known reason in childhood, and wanted to have 
surgery for aesthetic purposes due to opaque cornea.
ConClusions
Medulloepithelioma is a rare, slow-growing, 
and locally invasive childhood intraocular tumor. 
Poor vision and pain are the most common pre-
senting symptoms. Patients often are treated for 
glaucoma for years, with medulloepithelioma not 
being noticed due to its tendency to cause second-
ary glaucoma. Therefore, getting to know the tumor 
well and treating it is very important to prevent 
future complications.
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